Kennedy Capital Management LLC Has $16.83 Million Stock Position in AdaptHealth Corp. (NASDAQ:AHCO)

Kennedy Capital Management LLC increased its position in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 6.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,767,310 shares of the company's stock after acquiring an additional 99,326 shares during the period. Kennedy Capital Management LLC owned about 1.31% of AdaptHealth worth $16,825,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in AHCO. Assetmark Inc. bought a new position in shares of AdaptHealth in the 4th quarter valued at $28,000. Blue Trust Inc. increased its position in AdaptHealth by 24.1% during the 4th quarter. Blue Trust Inc. now owns 5,746 shares of the company's stock worth $55,000 after purchasing an additional 1,115 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its stake in AdaptHealth by 15.4% in the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company's stock valued at $121,000 after purchasing an additional 1,690 shares during the last quarter. KLP Kapitalforvaltning AS acquired a new stake in AdaptHealth in the fourth quarter valued at approximately $169,000. Finally, LRI Investments LLC grew its stake in shares of AdaptHealth by 32.0% during the third quarter. LRI Investments LLC now owns 15,331 shares of the company's stock worth $172,000 after buying an additional 3,713 shares during the last quarter. 82.67% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. Royal Bank of Canada raised their price objective on AdaptHealth from $11.00 to $14.00 and gave the company an "outperform" rating in a report on Wednesday, February 26th. Canaccord Genuity Group boosted their price target on AdaptHealth from $13.00 to $14.00 and gave the stock a "buy" rating in a report on Wednesday, February 26th. Truist Financial raised their price objective on shares of AdaptHealth from $12.00 to $14.00 and gave the company a "buy" rating in a report on Wednesday, February 26th. Robert W. Baird boosted their target price on shares of AdaptHealth from $14.00 to $16.00 and gave the stock an "outperform" rating in a report on Thursday, February 27th. Finally, UBS Group dropped their price target on shares of AdaptHealth from $12.00 to $11.00 and set a "buy" rating for the company in a research note on Thursday, February 13th. Five research analysts have rated the stock with a buy rating, According to MarketBeat.com, AdaptHealth has an average rating of "Buy" and an average target price of $13.80.

AdaptHealth Trading Down 2.4 %

NASDAQ:AHCO traded down $0.20 on Tuesday, reaching $8.02. 624,569 shares of the stock traded hands, compared to its average volume of 1,216,316. The firm has a market capitalization of $1.08 billion, a price-to-earnings ratio of -4.86, a price-to-earnings-growth ratio of 1.08 and a beta of 1.44. AdaptHealth Corp. has a 1-year low of $8.00 and a 1-year high of $11.90. The company has a current ratio of 1.24, a quick ratio of 1.00 and a debt-to-equity ratio of 1.34. The company's 50 day moving average is $9.82 and its 200-day moving average is $10.05.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.